Use of insulin sensitizing agents in outpatients with congestive heart failure appears safe, and may have important clinical benefits when compared with sulfonylureas and insulin

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Krasuski, RA; Smith, B; Carey, S; Galbreath, AD; Stajduhar, KC; Kwan, MD; Ellis, R; Freeman, GL

Published Date

  • September 1, 2005

Published In

Volume / Issue

  • 26 /

Start / End Page

  • 411 - 411

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1522-9645

International Standard Serial Number (ISSN)

  • 0195-668X

Conference Name

  • 27th Congress of the European-Society-of-Cardiology

Conference Location

  • Stockholm, SWEDEN

Conference Start Date

  • September 3, 2005

Conference End Date

  • September 7, 2005